ArticleOncotarget2017

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Juliette Palle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.